Navigation Links
Gates Foundation Adopts Fight against Encephalitis

The fight against Japanese encephalitis, a bird-borne Asian virus that has left a deadly trail of death or more commonly survivors with brain damage has been adopted by the the Bill & Melinda Gates Foundation. //

Today the virus is expanding its geographic reach and threatens several billion people on the planet. Dr. Julie Jacobson, director of the Japanese encephalitis program at Seattle-based Program for Appropriate Technology in Health (PATH) said, "This has been a disease of the world's poor."

According to Jacobson most of those killed or maimed by the virus have gone uncounted, misdiagnosed or regarded as the tragic, inevitable victims of an "orphan disease."

Today, the government of India celebrates with PATH for having immunized 9 million children against Japanese encephalitis that was part of a campaign aimed at reaching 11 million in high-risk districts.

Japanese encephalitis infects the brain and is likely to kill or cause permanent brain damage leading to serious illness in perhaps one in 25 infected, killing 30 percent and causing brain damage in perhaps 40 percent. Because of the poor monitoring of the disease it would be reasonable to expect that the annual death toll of 10,000 is a gross underestimate.

At present there is no viable treatment for the infection. Since children are at highest risk, the children of India are the ones being targeted for immunization.

"This is so exciting," said Jacobson, "For many years, at every twist and turn, it looked impossible. But now it's happening."

Credit for this goes in part to the $27 million grant which the Gates Foundation gave to PATH in 2003 to support a vaccination campaign in Asia. But the real reason behind its recent success is because Jacobson and her colleagues were willing to listen to Indian officials and change course.

In 2000, PATH received $25 million from the Gates Foundation to launch an immunization improv
'"/>




Page: 1 2 3

Related medicine news :

1. Bill Gates to Fund ￡28m for Malaria researc
2. Bill Gates Takes Personal Interest in AIDS Program
3. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
4. Gates Foundation to donate USD 104 million to TB Alliance
5. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. Clinton, Gates Highlight Treatment, Discrimination of AIDS
8. $68 million aid pours in from Gates Foundation to fight tropical diseases
9. Gates Foundation Grants $23mn for AIDS programme in India
10. Bill Gates pours in funds for diarrhea treatment reseach
11. Gates Foundation Pledges $3 Million to Fight Malaria in Africa
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...c Health suggests that obesity can//increase the r...dy existing. Obesity had been conclusively associa... diabetes, and certain forms of cancer. This is fo...ns have been established between obesity and asthm...
...entists its said that it is better// to go for sur...to wait and see if the disease progresses. Surgery...atectomy, is a common procedure. The researchers h...tectomy done in early stages of prostate cancer be...
... gastro esophageal reflux may be due// to wrong ea.... Nocturnal heartburns often lead to disturbed sle...part from being cause of other disease. Nocturnal ...is often linked with severe form of gastro esophag...
...ce that sheds new light on the details of how Hunt...patient. Huntington's disease is a genetic disorde...o think or move on his own. Early symptoms of the ..., forgetfulness, and inability to concentrate or r...
Other Medicine News:
(Date:9/4/2008)...RNewswire-FirstCall/ -- BioForm Medical,Inc. (Nas...ical study of,Polidocanol, conducted in Germany by...SLER & Co. GmbH (Kreussler), successfully met the ...DA as part of a New Drug Application,(NDA) process...(Efficacy and safety of,Aethoxysklerol compared to...
(Date:9/4/2008)...0 Women at More Than 100 Sites in the U.S., ANN A...ceuticals, a,privately-held biopharmaceutical comp...f compounds to treat endocrine, metabolic and,card...initiated a second,Phase 3 clinical trial of Ophen...-free oral therapy in development for the treatmen...
(Date:9/4/2008)...chedule with Two Abstracts Accepted for Presen...r 2008, BRIDGEWATER, N.J., Sept. 4 /...maceutical company focused on the treatment of,car... the appointment of,Peter L. Garrambone, Jr. to th...,s career includes more than 50 pharmaceutical,tra...
(Date:9/3/2008)... from chronically infected Hepatitis C,patients st...arlier in 2008, - Study is the first to show a s...viral effect of therapeutic Hepatitis C vaccinatio... into a second generation, vaccine formulated wit... activation, VIENNA,...
Breaking Medicine Technology:338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 1Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 2Millennium Biotechnologies Group Inc 28MBTG OB 29 Announces Appointment of Mark C Mirken as its President and Chief Operating Officer 525 3Tamoxifen Helps Treat Bipolar Disorder 1086 1Tamoxifen Helps Treat Bipolar Disorder 1086 2Tamoxifen Helps Treat Bipolar Disorder 1086 3Putting stem cell research on the fast track 359 1Putting stem cell research on the fast track 359 2Putting stem cell research on the fast track 359 3Putting stem cell research on the fast track 359 4Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit 1079 1Ken Sperling to Lead CIGNA HealthCare Retiree Solutions Unit 1079 2
...ESS WIRE)--Apr 12, 2007 - Affymax, Inc.,(Nasdaq:AF...s Phase,2 clinical trial of Hematide(TM) dosed mon... at the National Kidney Foundation (NKF),2007 Spri...ance-switch trial in patients previously treated w...ated that mean,hemoglobin (Hgb) levels can be main...
...The costs of eradicating,poliomyelitis from the re...t term, are much lower than the long term costs of... And a recently developed,monovalent vaccine is al...iomyelitis than an existing trivalent vaccine. The...ne and in an upcoming,issue of The Lancet. , Both ...
Other Medicine Technology:Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 2Affymax Announces Results From Phase 2 Clinical Trial of Hematide,for the Treatment of Anemia in Dialysis Patients 3Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3
...xpensive of the series. It has the ability to phot... of the cornea. The model comes with a 9 high-reso... of a patients corneal endothelium, you simply ask...rest. The left side of the chin rest allows you to...
The simplest, most accurate Ortho-K lens fitting system ever!
...ogy (oprifocon A) Contact Lenses are rigid gas per...process that temporarily corrects nearsightedness ... and removes them in the morning. During the day, ...y reduced., ,The Euclid Systems Orthokeratology (o...
...ontact lenses used for corneal refractive therapy,...ss (myopia). The patient wears the lenses overnigh...uring the day, nearsightedness is corrected or gre...ct lenses apply slight pressure to the center of t...
Medicine Products: